Atlas Energy Corp.

Atlas Energy Corp.

0.12
CAD
+0.01
(+4.35%)
-0.01EPS
84.97MMarket Cap
Nov 17Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.03
0.05
- -
- -
- -
Basic EPS, GAAP
-644.9
-155.77
-52.63
-48.62
-41.85
-12.88
-3.09
-2.07
-0.26
-0.6
-0.52
-0.23
- -
-0.01
Free Cash Flow per Basic Share
-83.79
-121.95
-41.16
-24.16
-27.3
-3.55
-1.1
-0.84
-0.83
-0.59
-0.44
-0.14
-0.01
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
320.36
116.41
78.12
22.4
-6.66
-0.76
1.39
-0.03
1.2
0.66
0.14
-0.02
0.04
0.04
Tangible Book Value per Share
320.36
116.41
78.12
22.4
-6.66
-0.76
0.99
-0.03
1.2
0.66
0.14
-0.02
0.04
0.04
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
14
16
24
25
25
27
351
629
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
-261,520
-168,460
-17,424.06
-2,241.17
-1,149.91
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
2
3
3
3
2
1
- -
- -
Net Income, GAAP
-2
-1
-1
-1
-2
-2
-45
-34
-6
-15
-13
-6
-1
-4
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
-891,320
-339,460
-4,616.54
-1,804.38
-1,111.69
- -
- -
- -
Working Capital
-1
-1
-1
-1
-1
-1
19
15
30
15
2
-1
27
25
LT Debt
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
2
1
- -
- -
Total Equity
1
1
1
1
- -
- -
22
-1
30
16
3
-1
27
25
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-105.03
-118.68
-61.41
-109.72
- -
- -
- -
- -
- -
-64.33
-131.54
- -
- -
-14.17

Capital Structure

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
629
629
629
Market Capitalization
104
107
85

Working Capital

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
28
27
26
Cash, Cash Equivalents & STI
27
27
25
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
1
Payables & Accruals
- -
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-2,675.91%
-2,230.23%
-5,502.77%
Free Cash Flow
297.68%
-15.05%
-2.55%
Net Income, GAAP
230.16%
-16.62%
-77.9%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
2
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.09
-0.07
-0.04
-0.03
-0.23
2025
-0.01
0.01
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Mark Hodgson
Full Time Employees
16
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Dome Tower Calgary AB Canada T2P 2Z1
IPO Date
Jan 8, 2021
Business
Atlas Energy Corp. (TSXV:ATLE; OTC:CANSF) is a Calgary-based international upstream oil and gas royalty and streaming company that acquires, manages and monetizes a diversified portfolio of royalty and streaming interests in upstream oil and gas assets across global markets. The company provides non-dilutive financing to operators through revenue- or production-based royalties and streams, enabling project development, acquisitions, exploration, appraisal and balance sheet strengthening; it targets deal sizes of US$25-50 million in top-tier assets operated by industry leaders in dynamic basins worldwide, including potential North American opportunities. Founded in 2019 and headquartered at 202, 1201-5th Street SW, Calgary, Alberta, Canada T2R 0Y6, Atlas employs a team of upstream professionals with experience across more than 70 countries and over US$19 billion in completed M&A and finance transactions. In June 2025, the company underwent a transformative recapitalization, completing a $30 million non-brokered equity private placement, appointing a new executive team led by President and CEO Mark Hodgson and reconstituting its board of directors, changing its name from Willow Biosciences Inc., consolidating shares on a one-for-five basis, transitioning to TSXV Sandbox listing under ATLE and voluntarily delisting from OTCQB while maintaining OTC Pink trading.

Company News

  • Atlas Energy Corp. Announces Appointments to Subsidiary Board and Extension of TSXV Sandbox Exit Deadline

  • Atlas Energy Reports First Quarter 2026 Financial Results

  • Atlas Energy Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Operations and Filing of Its 2025 AIF

  • WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

  • WILLOW BIOSCIENCES INC. ANNOUNCES COMPLETION OF SALE OF OPERATING SUBSIDIARY AND MANAGEMENT CHANGES

  • WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS

  • WILLOW BIOSCIENCES REPORTS 2024 FINANCIAL RESULTS AND UPDATE REGARDING SALE OF OPERATING SUBSIDIARY

  • WILLOW ANNOUNCES INITIATION OF STRATEGIC REVIEW PROCESS

  • WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

  • WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO

  • Willow Biosciences announces second collaboration with leading API manufacturer

  • WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT

  • Willow Biosciences inks commercial partnership with Kalsec

  • WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.

  • Willow Biosciences CEO confident in future after record revenue and new partnerships - ICYMI

  • Willow Biosciences achieves record revenue for the second quarter

  • WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

  • Willow Biosciences lands biopesticides collaboration worth $2M in year one

  • Willow Biosciences lands biopesticides collaboration worth $2mln in year one

  • WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDY